MesoMark – Mesothelioma Legal News

biomarkers, clinical trials, Fibroblast growth factor 18 (FGF18), High Mobility Group Box Protein 1 (HMGB1), malignant pleural mesothelioma, MesoMark, Mesothelioma blood tests, mesothelioma diagnosis, Mesothelioma News

New Mesothelioma Biomarker Shows Promise

By Jillian Duff December 27, 2016 December 27, 2016

A new biomarker (FGF18) has shown promise for patients with pleural mesothelioma according to a paper presented at the World Conference on Lung Canter.